72 cryptocurrency exchange-traded funds (ETFs) are pending approval from the SEC, with important deadlines for the XRP ETF disclosed.

An analyst has gathered information on all issuers of crypto-related Exchange Traded Funds (ETFs) that currently have pending applications with the SEC, along with the associated deadlines for decisions. The final decision deadline for the XRP ETFs submitted by three major issuers is reported to be October 2025. Recently, Bloomberg ETF analysts Eric Balchunas and James Seyffart revealed that the Litecoin ETFs submitted by Grayscale and Canary have a 2011% probability of being approved in 2025. The report also highlighted that the approval probabilities for Solana and Dogecoin related products are 211% and 231%, respectively. The US Securities and Exchange Commission (SEC) has 240 days from the date of acknowledgment to either approve or reject these applications. As the potential launch gains traction, prediction platform Polymarket has suggested there is a 79% likelihood that the SEC will approve the XRP ETF this year. The likelihood of approval by July 31 has dropped to 41%. To clarify crucial timelines and dispel any speculation, Balchunas has thoroughly assembled a list of ETF applications along with their filing dates and deadlines for decisions. He stated that there are 72 crypto ETFs awaiting approval from the SEC. Information on the ETFs and their respective final deadlines. Initially, Balchunas mentioned that the SOL ETFs submitted by VanEck, Canary, 21Shares, and Bitwise have a deadline for a final decision set for October 13, 2025. At the same time, the XRP exchange-traded funds submitted by Grayscale, 21Shares, Bitwise, and Canary are expected to have their final rulings made by October 18, 19, 20, and 24, respectively. WisdomTree, Coinshares, and Franklin Templeton have submitted applications that are expected to see decisions made by October 25. Additionally, according to an attached table, Grayscale’s Cardano ETF application is scheduled for a decision on April 11, 2025.